Legal & General Group Plc - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 58 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.8%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$9,000
-52.6%
8,450
-29.5%
0.00%
Q4 2019$19,0000.0%11,979
+15.8%
0.00%
Q3 2019$19,000
+11.8%
10,3470.0%0.00%
Q2 2019$17,00010,3470.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,484,714$2,658,0002.52%
ESSEX INVESTMENT MANAGEMENT CO LLC 549,750$984,0000.14%
BARD ASSOCIATES INC 88,184$158,0000.08%
EAM Investors, LLC 160,628$288,0000.07%
Regal Investment Advisors LLC 193,450$346,0000.07%
HighTower Advisors, LLC 5,284,838$9,460,0000.06%
HIGHLAND CAPITAL MANAGEMENT LP 545,000$976,0000.06%
Granite Point Capital Management, L.P. 329,000$589,0000.06%
Kore Private Wealth LLC 104,366$187,0000.04%
Verition Fund Management LLC 498,167$892,0000.04%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders